PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
GSE supplementation significantly reduced diastolic blood pressure (DBP) and heart rate (HR), though no significant effects were found for systolic blood pressure (SBP) or flow-mediated dilation (FMD) [PMID:34798267].
Supplementation (300 mg/day) led to significantly higher reductions in body weight, BMI, waist circumference, and waist-to-hip ratio compared to placebo [PMID:31713941].
GSE supplementation (250 mg proanthocyanidins) resulted in greater reductions in IL-6 and MDA compared to placebo [PMID:38419408].
Evidence suggests GSE may significantly lower total and low-density lipoprotein (LDL) cholesterol levels after four weeks [PMID:34067538].
Clinical evidence for the modulation of glycation markers, such as glycated hemoglobin, is limited and was not affected in the reviewed studies [PMID:34369228].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39796507 (2024) — Effect of Proanthocyanidins from Grape Seed Extract on Benign Prostatic Hyperplasia. · Nutrients
- 2.PMID: 32180617 (2020) — Grape seed extract: having a potential health benefits. · Journal of food science and technology
- 3.PMID: 32992712 (2020) — Grape (Vitis vinifera L.) Seed Oil: A Functional Food from the Winemaking Industry. · Foods (Basel, Switzerland)
- 4.PMID: 34798267 (2022) — The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: A systematic review and meta-analysis of controlled trials with duration- and dose-response analysis. · Pharmacological research
- 5.PMID: 38111186 (2024)